Progressive dysplasia and aneuploidy are hallmarks of mouse skin papillomas: relevance to malignancy - PubMed (original) (raw)
Progressive dysplasia and aneuploidy are hallmarks of mouse skin papillomas: relevance to malignancy
C M Aldaz et al. Proc Natl Acad Sci U S A. 1987 Apr.
Abstract
We report a systematic histopathologic study of papillomas at different times during promotion, correlating the results with those from cytogenetic analysis of the same tumors. Papillomas were induced in SENCAR mice by two-stage carcinogenesis (7,12-dimethylbenz[a]anthracene and phorbol 12-myristate 13-acetate). Individual tumors were randomly sampled at different times during promotion, and histopathologic and cytogenetic studies were carried out on every tumor. Early during promotion (10 weeks), most papillomas were well-differentiated hyperplastic lesions with mild or no cellular atypia. No tumors showed severe dysplastic changes. By 20 weeks of promotion, a dramatic drop had occurred in the number of lesions with no dysplasia. Most of the tumors presented moderate dysplasia, and some already showed severe dysplastic changes. At later stages (30-40 weeks), most of the papillomas were classified as moderately or severely dysplastic papillomas, and several were considered to be intrapapillomatous carcinomas. This histopathologic evaluation was supported by nuclear measurements performed on papillomas at different time points. Chromosomal abnormalities followed a similar trend. Papillomas seem to start as diploid lesions, but between 10 and 20 weeks of promotion, hyperdiploid cells can be observed in almost every tumor. In some cases the stem line was taken over by aneuploid clones. At 40 weeks of promotion, all papillomas were aneuploid, most of them with hyperdiploid stem lines. A positive correlation was found between the histological and cytogenetic studies, with the most aggressive and atypical tumors being the more aneuploid. These results support the idea that most, if not all, papillomas are truly premalignant lesions in different stages of the potential progression toward malignancy. Chromosomal abnormalities might play an important role in the sequence of events leading to malignancy.
Similar articles
- Sequential development of aneuploidy, keratin modifications, and gamma-glutamyltransferase expression in mouse skin papillomas.
Aldaz CM, Conti CJ, Larcher F, Trono D, Roop DR, Chesner J, Whitehead T, Slaga TJ. Aldaz CM, et al. Cancer Res. 1988 Jun 1;48(11):3253-7. Cancer Res. 1988. PMID: 2452689 - Early expression of type I K13 keratin in the progression of mouse skin papillomas.
Gimenez-Conti I, Aldaz CM, Bianchi AB, Roop DR, Slaga TJ, Conti CJ. Gimenez-Conti I, et al. Carcinogenesis. 1990 Nov;11(11):1995-9. doi: 10.1093/carcin/11.11.1995. Carcinogenesis. 1990. PMID: 1699681 - A multihit, multistage model of chemical carcinogenesis.
Owens DM, Wei S, Smart RC. Owens DM, et al. Carcinogenesis. 1999 Sep;20(9):1837-44. doi: 10.1093/carcin/20.9.1837. Carcinogenesis. 1999. PMID: 10469632 - Non-melanoma skin cancer in mouse and man.
Schwarz M, Münzel PA, Braeuning A. Schwarz M, et al. Arch Toxicol. 2013 May;87(5):783-98. doi: 10.1007/s00204-012-0998-9. Epub 2012 Dec 25. Arch Toxicol. 2013. PMID: 23266722 Review. - The premalignant nature of mouse skin papillomas: histopathologic, cytogenetic, and biochemical evidence.
Aldaz CM, Conti CJ. Aldaz CM, et al. Carcinog Compr Surv. 1989;11:227-42. Carcinog Compr Surv. 1989. PMID: 2465820 Review. No abstract available.
Cited by
- Defects in transforming growth factor-beta signaling cooperate with a Ras oncogene to cause rapid aneuploidy and malignant transformation of mouse keratinocytes.
Glick A, Popescu N, Alexander V, Ueno H, Bottinger E, Yuspa SH. Glick A, et al. Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14949-54. doi: 10.1073/pnas.96.26.14949. Proc Natl Acad Sci U S A. 1999. PMID: 10611318 Free PMC article. - Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression.
Hoot KE, Lighthall J, Han G, Lu SL, Li A, Ju W, Kulesz-Martin M, Bottinger E, Wang XJ. Hoot KE, et al. J Clin Invest. 2008 Aug;118(8):2722-32. doi: 10.1172/JCI33713. J Clin Invest. 2008. PMID: 18618014 Free PMC article. - Mechanisms of multistep carcinogenesis and carcinogen risk assessment.
Barrett JC. Barrett JC. Environ Health Perspect. 1993 Apr;100:9-20. doi: 10.1289/ehp.931009. Environ Health Perspect. 1993. PMID: 8354184 Free PMC article. Review. - Benzo[a]pyrene-induced murine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene.
Ruggeri B, DiRado M, Zhang SY, Bauer B, Goodrow T, Klein-Szanto AJ. Ruggeri B, et al. Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):1013-7. doi: 10.1073/pnas.90.3.1013. Proc Natl Acad Sci U S A. 1993. PMID: 8430068 Free PMC article. - The human Ha-ras oncogene induces genomic instability in murine fibroblasts within one cell cycle.
Denko NC, Giaccia AJ, Stringer JR, Stambrook PJ. Denko NC, et al. Proc Natl Acad Sci U S A. 1994 May 24;91(11):5124-8. doi: 10.1073/pnas.91.11.5124. Proc Natl Acad Sci U S A. 1994. PMID: 8197195 Free PMC article.
References
- Yale J Biol Med. 1980 Sep-Oct;53(5):367-84 - PubMed
- Environ Health Perspect. 1986 Sep;68:75-80 - PubMed
- Carcinogenesis. 1981;2(12):1375-9 - PubMed
- Cancer Res. 1982 Oct;42(10):4241-7 - PubMed
- Cancer Res. 1983 May;43(5):2034-41 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical